DPT (gene)
From Wikipedia, the free encyclopedia
|
Dermatopontin
|
||||||||||||||
| Identifiers | ||||||||||||||
| Symbol(s) | DPT; TRAMP | |||||||||||||
| External IDs | OMIM: 125597 MGI: 1928392 HomoloGene: 1458 | |||||||||||||
|
||||||||||||||
| RNA expression pattern | ||||||||||||||
| Orthologs | ||||||||||||||
| Human | Mouse | |||||||||||||
| Entrez | 1805 | 56429 | ||||||||||||
| Ensembl | ENSG00000143196 | ENSMUSG00000026574 | ||||||||||||
| Uniprot | Q07507 | Q9QZZ6 | ||||||||||||
| Refseq | NM_001937 (mRNA) NP_001928 (protein) |
NM_019759 (mRNA) NP_062733 (protein) |
||||||||||||
| Location | Chr 1: 166.93 - 166.97 Mb | Chr 1: 166.63 - 166.66 Mb | ||||||||||||
| Pubmed search | [1] | [2] | ||||||||||||
Dermatopontin, also known as DPT, is a human gene.[1]
Dermatopontin is an extracellular matrix protein with possible functions in cell-matrix interactions and matrix assembly. The protein is found in various tissues and many of its tyrosine residues are sulphated. Dermatopontin is postulated to modify the behavior of TGF-beta through interaction with decorin.[1]
[edit] References
[edit] Further reading
- Pochampally RR, Ylostalo J, Penfornis P, et al. (2007). "Histamine receptor H1 and dermatopontin: new downstream targets of the vitamin D receptor.". J. Bone Miner. Res. 22 (9): 1338–49. doi:. PMID 17547532.
- Gregory SG, Barlow KF, McLay KE, et al. (2006). "The DNA sequence and biological annotation of human chromosome 1.". Nature 441 (7091): 315–21. doi:. PMID 16710414.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:. PMID 15489334.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:. PMID 12477932.
- Shaheduzzaman S, Krishnan V, Petrovic A, et al. (2002). "Effects of HIV-1 Nef on cellular gene expression profiles.". J. Biomed. Sci. 9 (1): 82–96. PMID 11810028.
- Kuroda K, Okamoto O, Shinkai H (1999). "Dermatopontin expression is decreased in hypertrophic scar and systemic sclerosis skin fibroblasts and is regulated by transforming growth factor-beta1, interleukin-4, and matrix collagen.". J. Invest. Dermatol. 112 (5): 706–10. doi:. PMID 10233760.
- Okamoto O, Fujiwara S, Abe M, Sato Y (1999). "Dermatopontin interacts with transforming growth factor beta and enhances its biological activity.". Biochem. J. 337 ( Pt 3): 537–41. PMID 9895299.
- Superti-Furga A, Rocchi M, Schäfer BW, Gitzelmann R (1993). "Complementary DNA sequence and chromosomal mapping of a human proteoglycan-binding cell-adhesion protein (dermatopontin).". Genomics 17 (2): 463–7. doi:. PMID 8104875.
- Forbes EG, Cronshaw AD, MacBeath JR, Hulmes DJ (1994). "Tyrosine-rich acidic matrix protein (TRAMP) is a tyrosine-sulphated and widely distributed protein of the extracellular matrix.". FEBS Lett. 351 (3): 433–6. PMID 8082810.

